Chang Victor T, Xia Qi, Kasimis Basil
University of Medicine and Dentistry of New Jersey, USA.
J Support Oncol. 2005 Sep-Oct;3(5):377-82.
Anorexia and appetite assessment is an important priority in supportive oncology. A series of 156 veterans participating in a hematology oncology service completed the Functional Assessment of Anorexia/Cachexia Therapy (FAACT), the Functional Assessment of Cancer Therapy-General scale, the Memorial Symptom Assessment Scale Short Form (MSAS-SF), and the Zung Self-Rating Depression Scale and were followed for survival. The FAACT score correlated well with Karnofsky performance status, quality of life, and symptom distress subscales. A single appetite distress item from the MSAS-SF correlated well with these measures. Both appetite measures correlated with the presence of other symptoms and with concurrently measured hemoglobin, serum sodium, albumin, and cholesterol levels. These self-reported appetite measures were univariate predictors of survival and contributed additional prognostic information to data related to weight-loss distress. In a smaller study, the FAACT score correlated with a visual analogue measure of appetite and with the North Center Cancer Treatment Group appetite instrument. These data support use of these tools for the evaluation of appetite concerns among patients with advanced cancer.
厌食和食欲评估是支持性肿瘤学中的一项重要优先事项。156名参加血液肿瘤学服务的退伍军人完成了厌食/恶病质治疗功能评估（FAACT）、癌症治疗通用功能评估量表、纪念症状评估量表简表（MSAS-SF）和zung自评抑郁量表，并对其生存情况进行了随访。FAACT评分与卡氏功能状态、生活质量和症状困扰子量表密切相关。MSAS-SF中的一个单一食欲困扰项目与这些指标密切相关。两种食欲测量方法均与其他症状的存在以及同时测量的血红蛋白、血清钠、白蛋白和胆固醇水平相关。这些自我报告的食欲测量方法是生存的单变量预测因素，并为与体重减轻困扰相关的数据提供了额外的预后信息。在一项规模较小的研究中，FAACT评分与食欲的视觉模拟测量以及北中心癌症治疗组食欲工具相关。这些数据支持使用这些工具来评估晚期癌症患者的食欲问题。
